INVO Fertility, Inc. (IVF)
Nasdaq · Healthcare · Medical Devices
$0.829−3.04%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $3.8M
- P/E (trailing)
- 0.0
- 52-week range
- $0.7596 – $84.40
- 52-week change
- −97.31%
- EPS (trailing)
- $127.95
Fiscal year to Dec 2025
- Revenue
- $6.8M (+4.73%)
- Net income
- $23.3M
- Operating margin
- −105.8%
- Diluted EPS
- −$214.64
- Free cash flow
- −$7.1M
From the company’s annual report on SEC EDGAR.
About INVO Fertility, Inc.
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
Headquarters: Sarasota, United States · 40 employees · invofertility.com